Devin Scarborough examines the recent structural, regulatory, and political changes in the Food and Drug Administration brought on by the second term of the Trump administration. She argues that the Trump administration’s modifications have substantially weakened the FDA’s ability to protect the health of the American public by diminishing its ability to conduct sufficient research and implement necessary protections. She further analyzes the rising levels of foodborne illnesses that have coincided with FDA staffing cuts and decreases in food safety oversight, along with the increased risks associated with drug deregulation and political pressures within the agency. Ultimately, she concludes that the FDA’s institutional integrity and its ability to protect public health will continue to erode unless substantial corrective measures are taken.